Researchers at University of California, San Diego School of Medicine have developed a way to chemically disguise RNAi drugs so that they are able to enter cells. Once inside, cellular machinery converts these disguised drug precursors — called siRNNs — into active RNAi drugs.
Bess Marcus, PhD, has been appointed senior associate dean for Public Health with the UC San Diego School of Medicine.
Thomas Moore, MD has been named dean of Clinical Affairs and CEO for Faculty Practice at UC San Diego Health Sciences.
Comet, a new petascale supercomputer designed to transform advanced scientific computing by expanding access and capacity among traditional as well as non-traditional research domains, will soon be taking shape at the San Diego Supercomputer Center (SDSC) at the University of California, San Diego.
The Rady School of Management at UC San Diego entered the Bloomberg Businessweek rankings at 51st overall in its first ranking by the publication. Even more impressive, the school ranked 1st in the United States in Intellectual Capital, which is a quality measure of faculty research. The Rady School’s Full-time MBA program was the only MBA program in San Diego to be ranked by Businessweek.
With the help of mouse models, induced pluripotent stem cells (iPSCs) and the “tooth fairy,” researchers at the University of California, San Diego School of Medicine have implicated a new gene in idiopathic or non-syndromic autism.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
